248 related articles for article (PubMed ID: 17725732)
1. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets.
Dumont LJ; Gulliksson H; van der Meer PF; Murphy S; Nixon JG; de Wildt-Eggen J; Vandenbroeke T; Aubuchon JP
Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732
[TBL] [Abstract][Full Text] [Related]
2. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
Sandgren P; Shanwell A; Gulliksson H
Transfusion; 2006 May; 46(5):828-34. PubMed ID: 16686851
[TBL] [Abstract][Full Text] [Related]
3. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
[TBL] [Abstract][Full Text] [Related]
4. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative.
Dumont LJ; AuBuchon JP; Gulliksson H; Slichter SJ; Elfath MD; Holme S; Murphy JR; Rose LE; Popovsky MA; Murphy S
Transfusion; 2006 Aug; 46(8):1300-5. PubMed ID: 16934063
[TBL] [Abstract][Full Text] [Related]
5. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
6. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of shipped HLA-matched platelets.
Haddad SA; Lichtiger B; Klein HG
Transfusion; 2006 Aug; 46(8):1306-10. PubMed ID: 16934064
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
Heddle NM; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Blajchman MA; Kelton JG
Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
[TBL] [Abstract][Full Text] [Related]
9. Platelet ADP response deteriorates in synthetic storage media.
Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
[TBL] [Abstract][Full Text] [Related]
10. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
Valeri CR; Macgregor H; Ragno G
Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
[TBL] [Abstract][Full Text] [Related]
12. Platelet function in variable platelet split products intended for neonatal transfusion.
Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
[TBL] [Abstract][Full Text] [Related]
13. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
Lozano M; Galan A; Mazzara R; Corash L; Escolar G
Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
[TBL] [Abstract][Full Text] [Related]
14. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing.
Valeri CR; Ragno G; Khuri S
Transfusion; 2005 Dec; 45(12):1890-8. PubMed ID: 16371041
[TBL] [Abstract][Full Text] [Related]
15. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
18. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.
Li J; Goodrich L; Hansen E; Edrich R; Gampp D; Goodrich RP
Transfusion; 2005 Nov; 45(11):1750-8. PubMed ID: 16271100
[TBL] [Abstract][Full Text] [Related]
19. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days.
Valeri CR; Ragno G; Marks PW; Kuter DJ; Rosenberg RD; Stossel TP
Transfusion; 2004 Jun; 44(6):865-70. PubMed ID: 15157253
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions.
Vetlesen A; Mirlashari MR; Torsheim IA; Kjeldsen-Kragh J
Transfusion; 2005 Aug; 45(8):1349-55. PubMed ID: 16078925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
